The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global poultry diagnostics market size reached US$ 395.1 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 722.5 Million by 2027, exhibiting a growth rate (CAGR) of 10.53% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Several poultry diseases like chronic respiratory disease (CRD), infectious bronchitis (IB), Newcastle disease (ND), avian influenza (AI), and chicken anemia (CA) can occur due to inadequate nutritious feeding of poultry birds, their lack of proper care and management, and other factors. This can lead to significant losses in the poultry farming business. As a result, a thorough diagnosis of poultry diseases is required, which depends on the identification of vital organs, body structure, and disease symptoms and lesions. Poultry diagnostic services generally include necropsy examination, bacteriology, mycology, serology, pathology, toxicology, and molecular tests. They also involve quality assurance testing of incoming feed ingredients, preventing infection, food infectivity, and diseases.
One of the major challenges faced by the poultry industry is the loss of productivity due to diseases, which is catalyzing the demand for prudent health management. This, along with the increasing consumption of animal-derived products and rising concerns about food security, is stimulating market growth. Moreover, governing agencies of several countries are implementing strict health and food safety standards. Along with international organizations, they are also undertaking initiatives and launching campaigns to generate awareness about infectious diseases among poultry farmers. This, in turn, is positively influencing the demand for diagnostic infrastructure in the poultry industry. Furthermore, with the introduction of enzyme-linked immunosorbent assay (ELISA) tests that have high accuracy and cost efficiency, market participants are focusing on developing better testing tools and point-of-care (POC) diagnostics for newer ailments such as mortality syndrome. They are also entering into strategic collaborations and acquisitions to gain a competitive landscape, which is projected to strengthen the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global poultry diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on disease type, test type and service.
Breakup by Disease Type:
Breakup by Test Type:
Breakup by Service:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AgroBioTek Laboratories, BioChek B.V., Bionote Co. Ltd., Boehringer Ingelheim International GmbH, IDEXX Laboratories Inc., MEGACOR Diagnostik GmbH, QIAGEN N.V., Gezondheidsdienst voor Dieren B.V. (Royal GD), Thermo Fisher Scientific Inc., and Zoetis Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Disease Type, Test Type, Service, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||AgroBioTek Laboratories, BioChek B.V., Bionote Co. Ltd., Boehringer Ingelheim International GmbH, IDEXX Laboratories Inc., MEGACOR Diagnostik GmbH, QIAGEN N.V., Gezondheidsdienst voor Dieren B.V. (Royal GD), Thermo Fisher Scientific Inc., and Zoetis Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at